Medical societies unveil first CKM syndrome guideline

In a major shift for chronic disease management, leading medical societies have issued the first-ever clinical practice guideline for cardiovascular-kidney-metabolic syndrome, a condition that links heart disease, kidney disease, diabetes, and obesity. The guideline, released on June 9, 2026, by the American Heart Association and the American College of Cardiology in collaboration with the American Diabetes Association and the American Society of Nephrology, identifies excess abdominal fat as a central driver of the syndrome and calls for a unified, prevention-focused approach to care.

Cardiovascular-kidney-metabolic syndrome, or CKM syndrome, reflects the interconnected nature of these conditions, where having one increases the risk of developing the others. The guideline states that nearly 90% of U.S. adults have at least one risk factor for the syndrome, such as high blood pressure, abnormal cholesterol, high blood sugar, reduced kidney function, or excess weight. With obesity rates rising, the document underscores that managing weight is critical not for appearance but for metabolic health, as abdominal fat can cause inflammation leading to insulin resistance and vascular...